NGM Biopharmaceuticals Inc
NGMDelisted Apr 5, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426332
NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding NGM Biopharmaceuticals Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 75 | 1 | 0 | −74 |
| Shares | 34.6M | 3.10K | 0 | −34.6M (−100.0%) |
| Value | $55.1M | $4.00K | $0 | −$55.1M (−100.0%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held NGM Biopharmaceuticals Inc at the end of Q2 2024 but not at the end of Q1 2024.
None.
Sold out (74)
Institutions that held NGM Biopharmaceuticals Inc at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held NGM Biopharmaceuticals Inc at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Cutler Group LP | 3,100 | $4.00K |